Hempacco Signs Exclusive Distribution Agreement With Paradise Shop Mexico
Hempacco Co, Inc. (NASDAQ: HPCO) signed an exclusive distribution agreement with Paradise Shop Mexico.
Post-Accident Workforce Drug Positivity For Marijuana Reached 25-Year High In 2022, Quest Diagnostics Drug Testing Index Analysis Finds
The percentage of employees in the general U.S. workforce testing positive for marijuana following an on-the-job accident increased to its highest level in 25 years in 2022, according to a new analysis released by Quest Diagnostics (NYSE: DGX).
Heritage Entering The Recreational Cannabis-Infused Beverage Market In Canada
Heritage Cannabis Holdings Corp. (OTCQX: HERTF) (CSE:CANN) announced that it is entering the recreational cannabis-infused beverage market in Canada.
Enveric Biosciences Receives Notice Of Allowance From US Patent And Trademark Office For Novel Prodrug Of Psilocin
Enveric Biosciences, Inc. (NASDAQ: ENVB) has received a notice of allowance from the United States Patent and Trademark Office for a patent application involving EB-373, th
Evogene Q1 Revenue Grows 170% YoY, Here Are The Details
Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter period ending March 31, 2023, revealing revenues of $641,000, an increase of 170% compared to $237,000 in the same period the previous year.
California Cannabis Industry Alliance Backs Assemblymember Phil Ting’s Credit Law Bill
Kiva Sales & Service, CannaCraft, Calyx Peak, FundCanna, Glass House Brands (OTCQX: GLASF) (OTC: GHBWF), HERBL, Lowell Farms (OTCQX:
TerrAscend Opens Its Fifth Cookies Dispensary In Michigan
TerrAscend Corp. (OTCQX: TRSSF) (CSE:TER) announced that its subsidiary, Gage Cannabis Co. launched sales at its new flagship cannabis provisioning center in Oxford, Michigan.
InMed Pharmaceuticals Stock Trading Higher On Q3 Sales Growth Of 234%, Here Is What You Need To Know
InMed Pharmaceuticals Inc. (NASDAQ: INM) released its financial results for the third quarter of the fiscal year 2023 which ended March 31, 2023, revealing sales of $1 million, an increase of 234% compared to $309,585 in Q3 2022.
Delsta 9 Q1 Revenue Grows 35% YoY, What About Net Loss?
DELTA 9 CANNABIS INC. (TSX:DN) (OTCQB: DLTNF) released its financial results for the three-month period ending March 31, 2023, revealing net revenue of CA$16.9 million ($12.6 million) versus CA$12.5 million for the three-month period ending March 31, 2022, an increas